There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.

Looking at the bigger picture, we can see that one of the reasons ... By focusing on the start of the drug supply chain, benefits can be achieved throughout – including quicker time to market ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...